bpc 157 and sciatica BPC-157 Delayed Pro - 500mcg BPC-157 for Radiculopathy

Health authorities discourage the use of BPC-157 due to insufficient human safety data, and it is not approved by any drug regulatory agency for human use

International Journal of Molecular Medicine , 38 (6), 18151822

Patients experiencing signs of allergic reactions should discontinue the medication and seek appropriate medical attention

For deeper healing protocols, see our recovery peptide guide on BPC-157 and TB500

Without enough B12, nerves lose insulation and transmit signals poorly, which leads to tingling, weakness, and in severe cases, long-term nerve damage

Theres also an increased risk of benign liver tumors or liver cancer